Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
BlueLinx
BXC
$657M
| $1.15M | ﹤0.01% |
12,298
-7,081
| -37% | -$566K |
|
2152
1st Source
SRCE
$2.16B
| $1.15M | ﹤0.01% |
27,476
+5,928
| +28% | +$255K |
|
2153
Southside Bancshares
SBSI
$977M
| $1.15M | ﹤0.01% |
44,026
+19,990
| +83% | +$582K |
|
|
AMWD
2154
DELISTED
American Woodmark
AMWD
| $1.15M | ﹤0.01% |
15,071
+2,190
| +17% | +$127K |
|
2155
iShares Global Clean Energy ETF
ICLN
$2.38B
| $1.15M | ﹤0.01% |
62,502
| – | – |
|
2156
Innovative Industrial Properties
IIPR
$1.7B
| $1.15M | ﹤0.01% |
15,728
+887
| +6% | +$62.5K |
|
2157
GCM Grosvenor
GCMG
$809M
| $1.14M | ﹤0.01% |
151,469
+67,568
| +81% | +$504K |
|
2158
Tecnoglass Holdings Inc.
TGLS
$2.06B
| $1.14M | ﹤0.01% |
22,098
-6,712
| -23% | -$298K |
|
2159
Criteo S.A. Ordinary Shares
CRTO
$865M
| $1.14M | ﹤0.01% |
33,741
-6,108
| -15% | -$197K |
|
2160
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $1.14M | ﹤0.01% |
36,800
-34,400
| -48% | -$1.05M |
|
2161
Edgewell Personal Care
EPC
$1.31B
| $1.14M | ﹤0.01% |
27,519
+798
| +3% | +$34.1K |
|
2162
Gold Fields
GFI
$33.5B
| $1.13M | ﹤0.01% |
81,965
+41,522
| +103% | +$631K |
|
2163
Embecta
EMBC
$209M
| $1.13M | ﹤0.01% |
52,479
+10,911
| +26% | +$298K |
|
2164
Univest Financial
UVSP
$1.21B
| $1.13M | ﹤0.01% |
62,588
+4,162
| +7% | +$81.5K |
|
|
BLU
2165
DELISTED
BELLUS Health Inc.
BLU
| $1.13M | ﹤0.01% |
76,450
-276,571
| -78% | -$3.67M |
|
2166
ACM Research
ACMR
$5.5B
| $1.12M | ﹤0.01% |
85,948
+61,661
| +254% | +$650K |
|
2167
Oxford Industries
OXM
$576M
| $1.12M | ﹤0.01% |
11,418
-7,624
| -40% | -$781K |
|
2168
Lindsay Corp
LNN
$1.17B
| $1.12M | ﹤0.01% |
9,403
-287
| -3% | -$35.6K |
|
2169
Freshworks
FRSH
$3.2B
| $1.12M | ﹤0.01% |
63,825
+57,631
| +930% | +$867K |
|
2170
Dorman Products
DORM
$4.1B
| $1.12M | ﹤0.01% |
14,222
+830
| +6% | +$69.9K |
|
2171
Heritage Financial
HFWA
$1.21B
| $1.12M | ﹤0.01% |
69,198
+31,805
| +85% | +$554K |
|
2172
Scansource
SCSC
$1.17B
| $1.12M | ﹤0.01% |
37,851
-305
| -0.8% | -$8.82K |
|
2173
Novartis
NVS
$293B
| $1.11M | ﹤0.01% |
10,978
+10,446
| +1,964% | +$1.04M |
|
2174
ProPetro Holding
PUMP
$1.36B
| $1.11M | ﹤0.01% |
134,277
+10,870
| +9% | +$79.8K |
|
|
MNTN
2175
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
| $1.11M | ﹤0.01% |
103,880
| – | – |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.